Stay updated on MK-3475 and Gemcitabine in NSCLC Clinical Trial
Sign up to get notified when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.

Latest updates to the MK-3475 and Gemcitabine in NSCLC Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive content changes to the study details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedLocations section now includes Oregon; Oregon Locations removed. The page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows 'Results Submitted' instead of 'No Results Posted' and the revision is updated to v3.3.2.SummaryDifference0.1%

- Check61 days agoChange DetectedA government funding status notice was removed from the page; this administrative banner does not affect the study details, eligibility criteria, outcomes, or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedThe page shows routine updates (e.g., last update date); core study content and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check104 days agoChange DetectedCore content updated with a government-lapse notice and new version v3.2.0; previous v3.1.0 deletion confirms the upgrade.SummaryDifference5%

Stay in the know with updates to MK-3475 and Gemcitabine in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.